| 2022-07-26 7:9:25 am |
Stealth BioTherapeutics: A Net-Net Biopharma Going Private |
SeekingAlpha |
| Jul-14-22 10:57AM |
The Petri Dish: Verve's base editing is being tested in humans, Moderna updates boosters again |
American City Business Journals |
| Jul-11-22 05:15PM |
STEALTH BIOTHERAPEUTICS ANNOUNCES RECEIPT OF NON-COMPLIANCE NOTICE FROM NASDAQ |
PR Newswire |
| Jun-27-22 07:30AM |
Stealth BioTherapeutics Corp Announces Receipt of Preliminary Non-Binding Proposal |
PR Newswire |
| Jun-14-22 07:25AM |
Stealth BioTherapeutics Granted Pre-NDA Meeting for Elamipretide as a Potential Treatment for Barth Syndrome |
PR Newswire |
| Jun-08-22 10:26AM |
Healthcare Breakthroughs: NVAX, MITO, LMLLF, NMLSF; Life Sciences Leaders Report Latest Advances in Vaccines, Novel Therapeutics for Autism, Neurodegenerative, Oncology, and Glaucoma |
GlobeNewswire |
| Jun-08-22 09:38AM |
Why Stealth BioTherapeutics Shares Are Surging Today? |
Benzinga |
| Jun-08-22 07:20AM |
Stealth BioTherapeutics Presents New SBT-272 Data Demonstrating Improvement in Upper Motor Neuron Function in ALS Disease Model at Keystone Neurodegeneration Symposium |
PR Newswire |
| May-31-22 07:25AM |
Stealth BioTherapeutics Receives Orphan Drug Designation from the European Medicines Agency for Elamipretide for the Treatment of Myopathic Mitochondrial DNA Depletion Syndrome |
PR Newswire |
| May-23-22 07:30AM |
Stealth BioTherapeutics Announces Data from the Phase 2 ReCLAIM-2 Study of Elamipretide in Geographic Atrophy at the Clinical Trials at the Summit Meeting 2022 |
PR Newswire |
| May-12-22 07:30AM |
Stealth BioTherapeutics Receives Orphan Drug Designation from FDA for Elamipretide for Treatment of Duchenne Muscular Dystrophy |
PR Newswire |
| May-03-22 07:15AM |
MITO: Positive Data Despite Miss for MITO |
Zacks Small Cap Research |
| May-02-22 09:15AM |
Stealth Bio Posts Disappointing Elamipretide Data From Mid-Stage Geographic Atrophy Study |
Benzinga |
| May-02-22 07:30AM |
STEALTH BIOTHERAPEUTICS ANNOUNCES DATA FROM RECLAIM-2 PHASE 2 TRIAL OF ELAMIPRETIDE IN GEOGRAPHIC ATROPHY |
PR Newswire |
| Apr-11-22 08:30AM |
Stealth BioTherapeutics Announces $8.5 Million in Equity Financings |
PR Newswire |
| Apr-01-22 09:10AM |
MITO: Stealth BioTherapeutics Treatments Gain Momentum |
Zacks Small Cap Research |
| Mar-31-22 08:23AM |
Stealth Bio's SBT-272 Shows Encouraging Action In Huntington's Disease Animal Model |
Benzinga |
| Mar-30-22 04:30PM |
Stealth BioTherapeutics Announces New SBT-272 Data and Trial Initiation |
PR Newswire |
| Mar-28-22 07:30AM |
Stealth BioTherapeutics Receives Orphan Drug Designation from FDA for Elamipretide for the Treatment of Friedreich's Ataxia |
PR Newswire |
| Mar-24-22 07:30AM |
Stealth BioTherapeutics Announces New Data on Complement Gene Expression and Cell Survival in Dry AMD to be Presented at ARVO (2022) |
PR Newswire |
| Mar-17-22 04:30PM |
Stealth BioTherapeutics to Host Virtual Event on the Potential of Elamipretide in Treatment of Geographic Atrophy in Dry Age-Related Macular Degeneration |
PR Newswire |
| Mar-17-22 06:12AM |
Stealth BioTherapeutics Showcases New Nonclinical Data From Duchenne Muscular Dystrophy Program |
Benzinga |
| Mar-16-22 04:30PM |
Stealth BioTherapeutics Showcases New Duchenne Muscular Dystrophy Nonclinical Data at the 2022 Muscular Dystrophy Association and Clinical and Scientific Conference |
PR Newswire |
| Mar-14-22 08:35AM |
Life Sciences Investor Forum Presentations Now Available for On-Demand Viewing |
GlobeNewswire |
| Mar-09-22 05:00PM |
Stealth BioTherapeutics to Present at Upcoming March Investor Conferences |
PR Newswire |
| Mar-08-22 08:35AM |
UPDATE Life Sciences Investor Forum: Company Executives Present Live March 10th |
GlobeNewswire |
| Feb-23-22 06:30AM |
MITO: Seeking to Repair Mitochondria to Solve Unsolvable Medical Conditions |
Zacks Small Cap Research |
| Feb-22-22 07:30AM |
Stealth BioTherapeutics to Present at Mitochondria-Targeted Drug Development Summit |
PR Newswire |
| Feb-15-22 07:30AM |
Last Patient Completes Treatment in Stealth BioTherapeutics' Phase 2 Geographic Atrophy Clinical Trial |
PR Newswire |
| Feb-11-22 05:30PM |
Stealth BioTherapeutics Receives Nasdaq Notification Regarding Minimum Market Value Of Publicly Held Shares Requirement |
PR Newswire |
| Feb-08-22 07:30AM |
Stealth BioTherapeutics Announces Oral Presentation of New Duchenne Muscular Dystrophy Data at the 2022 Muscular Dystrophy Association Clinical and Scientific Conference |
PR Newswire |
| Jan-13-22 11:15AM |
The Petri Dish: Merck names Cambridge site leader, HotSpot inks $40M+ deal |
American City Business Journals |
| Jan-07-22 04:30PM |
Stealth BioTherapetuics Receives Nasdaq Notifications Regarding Minimum Bid And Market Value Requirements |
PR Newswire |
| Jan-04-22 07:30AM |
Stealth BioTherapeutics to Present at 2022 H.C. Wainwright BioConnect Virtual Conference |
PR Newswire |
| Dec-20-21 07:30AM |
Stealth BioTherapeutics Reports Positive Pre-IND Meeting for Duchenne Muscular Dystrophy |
PR Newswire |
| Dec-13-21 07:30AM |
Stealth BioTherapeutics Provides Update On Clinical Stage Rare Disease Programs |
PR Newswire |
| Nov-11-21 07:30AM |
Stealth BioTherapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights |
PR Newswire |
| Nov-04-21 07:30AM |
Stealth BioTherapeutics to Report Third Quarter Financial Results on Thursday, November 11 |
PR Newswire |
| Oct-20-21 09:14AM |
Stealth Bio Stock Falls On FDA Refusal to File Letter For Barth Syndrome Candidate |
Benzinga |
| Oct-20-21 07:30AM |
Stealth BioTherapeutics Receives Refusal to File Letter from the FDA |
PR Newswire |
| Oct-07-21 05:00PM |
Stealth BioTherapeutics Presents Positive SBT-272 Preclinical Data at 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting |
PR Newswire |
| Oct-06-21 04:59PM |
The Petri Dish: Takeda taps Selecta for gene therapy, BICO makes another buy |
American City Business Journals |
| Oct-06-21 04:15PM |
Horizon Technology Finance Provides Third Quarter 2021 Portfolio Update |
PR Newswire |
| Oct-04-21 07:30AM |
Stealth BioTherapeutics Completes a $25 Million Debt Financing with Horizon Technology Finance |
PR Newswire |
| Sep-23-21 11:13AM |
Stealth Bio Posts Encouraging Preclinical Data In Parkinson's Animal Studies |
Benzinga |
| Sep-23-21 07:30AM |
Stealth BioTherapeutics Presents Positive SBT-272 Preclinical Data at International Parkinson and Movement Disorder Society Virtual Congress 2021 |
PR Newswire |
| Sep-14-21 07:30AM |
Stealth BioTherapeutics to Showcase Leadership in Retinal Mitochondrial Health with Clinical Updates at Ophthalmic Conferences |
PR Newswire |
| Sep-07-21 04:30PM |
Stealth BioTherapeutics to Present at Upcoming September Virtual Investor Conferences |
PR Newswire |
| Aug-25-21 11:28AM |
Stealth (MITO) Files NDA for Ultra-Rare Disease Candidate |
Zacks |
| Aug-24-21 09:29AM |
Stealth Bio Files US Application For Ultra Rare Genetic Disease Candidate |
Benzinga |
| Aug-24-21 07:30AM |
Stealth BioTherapeutics Submits Elamipretide New Drug Application to FDA for Treatment of Barth Syndrome |
PR Newswire |
| Aug-23-21 07:30AM |
Stealth BioTherapeutics Strengthens IP Portfolio with Issuance of U.S. Patents Covering Elamipretide for Barth Syndrome |
PR Newswire |
| Aug-11-21 07:30AM |
Stealth BioTherapeutics to Present at H.C. Wainwright Ophthalmology Virtual Healthcare Conference |
PR Newswire |
| Aug-05-21 07:30AM |
Stealth BioTherapeutics Reports Second Quarter 2021 Financial Results And Recent Business Highlights |
PR Newswire |
| Jul-30-21 04:30PM |
Stealth BioTherapeutics to Report Second Quarter Financial Results on Thursday, August 5 |
PR Newswire |
| Jul-08-21 06:11AM |
Stealth BioTherapeutics (MITO) Sees Hammer Chart Pattern: Time to Buy? |
Zacks |
| Jul-07-21 04:30PM |
Stealth BioTherapeutics Joins the Rare Disease Company Coalition |
PR Newswire |
| Jul-06-21 06:23AM |
Stealth BioTherapeutics'(NASDAQ:MITO) Share Price Is Down 19% Over The Past Year. |
Simply Wall St. |
| Jun-18-21 11:38AM |
Is MITO Stock A Buy Here? |
Insider Monkey |
| Jun-01-21 04:30PM |
Stealth BioTherapeutics Receives Orphan Drug Designation from the European Medicines Agency for Elamipretide for the Treatment of Barth Syndrome |
PR Newswire |
| May-28-21 07:30AM |
Stealth BioTherapeutics to Present at Jefferies Virtual Healthcare Conference |
PR Newswire |
| May-18-21 07:30AM |
Stealth BioTherapeutics Reports First Quarter 2021 Financial Results And Recent Business Highlights |
PR Newswire |
| May-18-21 06:45AM |
Stealth BioTherapeutics Corp. to Host Earnings Call |
ACCESSWIRE |
| May-18-21 06:21AM |
Stealth BioTherapeutics Stock Surges On $30M Funding To Advance Elamipretide Development |
Benzinga |
| May-17-21 05:00PM |
Stealth BioTherapeutics Announces Additional Development Financing to Advance Elamipretide Clinical Trials |
PR Newswire |
| May-17-21 07:30AM |
Stealth BioTherapeutics Announces Poster Presentation at American College of Cardiology (ACC) Annual Meeting |
PR Newswire |
| May-13-21 04:30PM |
Stealth BioTherapeutics to Present at Upcoming Investor Conferences in May |
PR Newswire |
| May-11-21 04:30PM |
Stealth BioTherapeutics to Report First Quarter Financial Results on Tuesday, May 18, 2021 |
PR Newswire |
| May-05-21 04:30PM |
Stealth BioTherapeutics Showcases Data for Elamipretide in Dry Age-Related Macular Degeneration at the 2021 ARVO Annual Meeting |
PR Newswire |
| Apr-28-21 04:30PM |
Stealth BioTherapeutics Announces Poster Presentation at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Virtual Annual Meeting |
PR Newswire |
| Apr-26-21 07:30AM |
Stealth BioTherapeutics CEO to Give Keynote Presentation at Mitochondria-Targeted Drug Development Summit |
PR Newswire |
| Apr-06-21 07:30AM |
Stealth BioTherapeutics Reports Fiscal Year 2020 Financial Results And Recent Business Highlights |
PR Newswire |
| Apr-06-21 06:30AM |
Stealth BioTherapeutics Corp. to Host Earnings Call |
ACCESSWIRE |
| Mar-31-21 05:30PM |
Stealth BioTherapeutics to Report Full Year 2020 Financial Results on Tuesday, April 6, 2021 |
PR Newswire |
| Mar-16-21 07:30AM |
Stealth BioTherapeutics Announces Promotion of Marty Redmon to Chief Research & Development Officer |
PR Newswire |
| Mar-02-21 04:30PM |
Stealth BioTherapeutics to Present at Upcoming Investor Conferences in March |
PR Newswire |
| Feb-10-21 07:54AM |
Stealth BioTherapeutics Announces Pricing Of $4.7 Million Registered Direct Offering Of American Depositary Shares |
PR Newswire |
| Jan-07-21 04:30PM |
Stealth BioTherapeutics to Participate in Upcoming January Investor Conferences |
PR Newswire |
| Jan-06-21 07:30AM |
The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping |
Benzinga |
| Jan-05-21 08:00PM |
Stealth BioTherapeutics Granted Pre-NDA Meeting For Elamipretide As A Treatment For Cardiomyopathy In Barth Syndrome |
PR Newswire |
| Dec-09-20 04:30PM |
Stealth BioTherapeutics Announces Elamipretide Clinical Data to be Presented at the 13th International Conference on Cachexia, Sarcopenia and Wasting Diseases |
PR Newswire |
| Dec-07-20 08:00AM |
Stealth BioTherapeutics Announces Appointment of Eve E. Slater, M.D., F.A.C.C. to its Board of Directors |
PR Newswire |
| Nov-29-20 05:14PM |
Is Stealth BioTherapeutics Corp (MITO) A Good Stock To Buy? |
Insider Monkey |
| Nov-24-20 04:30PM |
Stealth BioTherapeutics Announces Closing of $3.2 Million Registered Direct Offering |
PR Newswire |
| Nov-22-20 03:45AM |
Reflecting on Stealth BioTherapeutics' (NASDAQ:MITO) Share Price Returns Over The Last Year |
Simply Wall St. |
| Nov-20-20 08:00AM |
Stealth BioTherapeutics Announces $3.2 Million Registered Direct Offering |
PR Newswire |
| Nov-06-20 09:31PM |
Stealth BioTherapeutics Corp (MITO) Q3 2020 Earnings Call Transcript |
Motley Fool |
| Nov-05-20 07:30AM |
Stealth BioTherapeutics Reports Third Quarter 2020 Financial Results And Recent Business Highlights |
PR Newswire |
| Nov-04-20 05:00PM |
Stealth BioTherapeutics Announces Development Financing To Advance Elamipretide Clinical Trials |
PR Newswire |
| Oct-30-20 04:30PM |
Stealth BioTherapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 |
PR Newswire |
| Oct-19-20 04:30PM |
Stealth BioTherapeutics Announces Poster Presentation at American Society of Human Genetics (ASHG) Virtual Annual Meeting |
PR Newswire |
| Sep-23-20 04:30PM |
Stealth BioTherapeutics Announces Poster Presentation at 2020 Annual NEALS Meeting |
PR Newswire |
| Sep-10-20 05:30PM |
Stealth BioTherapeutics to Present at Upcoming Investor Conferences in September |
PR Newswire |
| Aug-06-20 07:30AM |
Stealth BioTherapeutics Reports Second Quarter 2020 Financial Results and Recent Business Highlights |
PR Newswire |
| Jul-30-20 08:30AM |
Stealth BioTherapeutics to Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020 |
PR Newswire |
| Jun-17-20 08:30AM |
Stealth BioTherapeutics to Present at BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference |
PR Newswire |
| Jun-04-20 06:40PM |
Hedge Funds Getting Interested In Stealth BioTherapeutics Corp (MITO) |
Insider Monkey |
| May-26-20 04:30PM |
Stealth BioTherapeutics to Present at Jefferies Virtual Healthcare Conference |
PR Newswire |
| May-14-20 09:41AM |
Stealth BioTherapeutics Corp (MITO) Shares March Higher, Can It Continue? |
Zacks |
| May-13-20 08:30AM |
Stealth BioTherapeutics to Present at UBS Virtual Global Healthcare Conference |
PR Newswire |
| May-08-20 06:30PM |
Stealth BioTherapeutics Corp (MITO) Q1 2020 Earnings Call Transcript |
Motley Fool |